Inhibition of HIV-1 infection by an intramolecular antisense peptide to T20 in gp160
- PMID: 10789510
- DOI: 10.1111/j.1348-0421.2000.tb02485.x
Inhibition of HIV-1 infection by an intramolecular antisense peptide to T20 in gp160
Abstract
Antisense amino acids are amino acids which can be translated from the corresponding anti-codons of a sense amino acid. Antisense peptides encoded by the noncoding DNA strand have a tendency to interact with each other. We have demonstrated that antisense peptide sequences are present intramolecularly, and these may contribute to the folding and maintenance of the tertiary structure of a protein. T20 is a synthetic peptide with an amino acid sequence in the gp41 of HIV-1 and has been demonstrated to be a potent inhibitor of HIV-1 infection. We searched for intramolecular peptide sequences which are antisense to portions of T20. A synthetic peptide (TA-1L) consisting of amino acids 84 to 97 of gp160, which contains an antisense peptide sequence (TA-1) to T20, was shown to inhibit HIV-1(IIIB) infection of MT-4 cells. Interaction of these antisense peptides could be involved in sustaining HIV-1 infectivity. The TA-1L site, which exists in the C1 domain of gp160, is highly homologous among strains of HIV-1, especially at TA-1 and in the amino acids flanking the C terminus. Although the TA-1 sites of 18 out of 30 HIV-1 strains were antisense to the T20 region, those of the remaining 12 strains, including HIV-1(MN), were not. However, TA-1L inhibited infection by HIV-1(MN), which has no antisense peptide in T20 corresponding to TA-1, although the inhibitory effect was weaker. TA-1L may thus also interfere with the gp160 interaction with CD4, which has an antisense sequence to TA-1.
Similar articles
-
The C4 region as a target for HIV entry inhibitors--NMR mapping of the interacting segments of T20 and gp120.FEBS J. 2015 Dec;282(24):4643-57. doi: 10.1111/febs.13541. Epub 2015 Oct 22. FEBS J. 2015. PMID: 26432362 Free PMC article.
-
Inhibition of HIV-1 infection by a fusion domain binding peptide from the HIV-1 envelope glycoprotein GP41.Biochem Biophys Res Commun. 1993 Sep 15;195(2):533-8. doi: 10.1006/bbrc.1993.2078. Biochem Biophys Res Commun. 1993. PMID: 8373393
-
The LLSGIV stretch of the N-terminal region of HIV-1 gp41 is critical for binding to a model peptide, T20.Protein Eng. 2003 Apr;16(4):311-7. doi: 10.1093/proeng/gzg036. Protein Eng. 2003. PMID: 12736375
-
Peptide and non-peptide HIV fusion inhibitors.Curr Pharm Des. 2002;8(8):563-80. doi: 10.2174/1381612024607180. Curr Pharm Des. 2002. PMID: 11945159 Review.
-
HIV-1 gp41 heptad repeat 2 (HR2) possesses an amino acid domain that resembles the allergen domain in Aspergillus fumigatus Asp f1 protein: review, hypothesis and implications.Virus Genes. 2007 Jun;34(3):233-40. doi: 10.1007/s11262-007-0082-3. Epub 2007 Mar 1. Virus Genes. 2007. PMID: 17333401 Review.
Cited by
-
Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus.Biomaterials. 2013 Apr;34(13):3511-22. doi: 10.1016/j.biomaterials.2013.01.075. Epub 2013 Feb 13. Biomaterials. 2013. PMID: 23415044 Free PMC article.
-
Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells.J Virol. 2004 Oct;78(20):11334-9. doi: 10.1128/JVI.78.20.11334-11339.2004. J Virol. 2004. PMID: 15452254 Free PMC article.
-
Can Carbon Quantum Dots (CQDs) or Boron Compounds be an Ultimate Solution for COVID-19 Therapy?Iran J Pharm Res. 2021 Fall;20(4):9-20. doi: 10.22037/ijpr.2021.114856.15071. Iran J Pharm Res. 2021. PMID: 35194423 Free PMC article. Review.
-
Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus.J Virol. 2013 Dec;87(24):13134-40. doi: 10.1128/JVI.02433-13. Epub 2013 Sep 25. J Virol. 2013. PMID: 24067982 Free PMC article.
-
Potential "biopeptidal" therapeutics for severe respiratory syndrome coronaviruses: a review of antiviral peptides, viral mechanisms, and prospective needs.Appl Microbiol Biotechnol. 2021 May;105(9):3457-3470. doi: 10.1007/s00253-021-11267-1. Epub 2021 Apr 19. Appl Microbiol Biotechnol. 2021. PMID: 33876282 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials